Red blood cells may hold key to heart attack risk in diabetes
NCT ID NCT07151222
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study investigates how red blood cells influence heart attack risk in people with type 2 diabetes. Researchers will collect blood from 500 participants (patients with heart attacks, type 2 diabetes, and healthy volunteers) and test the cells in the lab to understand their effects on heart and blood vessel function. The goal is to uncover new ways to prevent heart damage.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this research could point toward new treatments that target red blood cells to reduce heart attack risk in people with type 2 diabetes.
What could go wrong
This is an early-stage, observational study using lab tests, not a treatment trial. It may not lead to any new therapies, and findings may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karolinska Institutet
RECRUITINGStockholm, Swsden, 17176, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••